Key facts
- It has raised $13.9M; the latest was Seed Round ($13.9M) in Jul 2025.
- Notable investors include Legend Capital, Optics Valley Industry Investment, Hubei Provincial Science and Technology Investment Group, Mingxi Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Fairy Life Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Fairy Life Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fairy Life Sciences
Operator of a linear array structured light, Linear Array Spot Excitation (LASE) imaging streaming technology platform based in Wuhan, China. The company's technology utilises micro-nano diffraction optical innovation to upgrade the strip-shaped excitation spot of traditional flow cytometers to a linear array structure, thereby providing flow cytometers with imaging capabilities.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Fairy Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fairy Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fairy Life Sciences in its N-PORT filings yet. We sweep new filings monthly.